Insights
Strategic Navigation of Pharmaceutical Insolvency in India
India’s Pharma Industry and Pharmaceutical Insolvency The Indian pharmaceutical industry is a study in contrasts. While it stands as the world’s third-largest producer by volume rightfully earning the…
4 min read
The Go-To-Market Reality: Why Most IT Companies Struggle to Scale (And How to Fix It)
The Go-To-Market Reality: Why Most IT Companies Struggle to Scale Their Go-to-Market Strategy for IT Companies An essential guide for IT MSMEs navigating growth, competition, and market chaos.…
4 min read
Private Placement Strategy in the Pharmaceutical Industry
How a Pharma Private Placement Strategy helps companies overcome funding gaps, R&D risk, and competitive pressure The pharmaceutical industry is capital-intensive, regulation-driven, and long-cycle by nature. From early-stage…
4 min read
Pharma M&A Success: Strategic Insights, Key Drivers, and the Solvencis Advantage
Pharmaceutical M&A has become a powerful growth strategy, enabling companies to accelerate innovation, expand pipelines, enter new therapeutic areas, and access breakthrough technologies. In 2024, global pharma M&A…
4 min read
Why Financial Insolvency and Bankruptcy Destroy Value and How Structured Resolution Can Restore Stability
A Strategic Resolution Framework for Sustainable Financial Stability in Financial Insolvency and Bankruptcy The finance industry depends on trust, cash flow, and proper risk control. Even strong financial…
4 min read
Finance Go-to-Market Strategy(GTM): Addressing Structural Challenges in the Finance Industry for Sustainable Growth
How a Finance Go-to-Market Strategy can help institutions overcome regulatory complexity, trust gaps, and execution risk. The finance industry operates in a high-trust, high-regulation environment where security, compliance,…
4 min read
